Adachi J, , Ookawa K, & Kohno T, et al: Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression. Cell Death Differ 5:148–155, 1998 Adachi J, Ookawa K, Kohno T, et al: Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression. Cell Death Differ 5:148–155, 1998

Adachi J, Ookawa K, Kohno T, et al: Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression. Cell Death Differ 5:148–155, 1998Adachi J, Ookawa K, Kohno T, et al: Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression. Cell Death Differ 5:148–155, 1998)| false
• Search Google Scholar
• Export Citation

Adachi J, , Ookawa K, & Shiseki M, et al: Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma. Cell Growth Differ 7:879–886, 1996 Adachi J, Ookawa K, Shiseki M, et al: Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma. Cell Growth Differ 7:879–886, 1996

Adachi J, Ookawa K, Shiseki M, et al: Induction of apoptosis but not G₁ arrest by expression of the wild-type p53 gene in small cell lung carcinoma. Cell Growth Differ 7:879–886, 1996Adachi J, Ookawa K, Shiseki M, et al: Induction of apoptosis but not G₁ arrest by expression of the wild-type p53 gene in small cell lung carcinoma. Cell Growth Differ 7:879–886, 1996)| false
• Search Google Scholar
• Export Citation

Arap W, , Knudsen ES, & Wang JYJ, et al: Point mutations can inactivate in vitro and in vivo activities of p16INK4a/CDKN2A in human glioma. Oncogene 14:603–609, 1997 Arap W, Knudsen ES, Wang JYJ, et al: Point mutations can inactivate in vitro and in vivo activities of p16INK4a/CDKN2A in human glioma. Oncogene 14:603–609, 1997

Arap W, Knudsen ES, Wang JYJ, et al: Point mutations can inactivate in vitro and in vivo activities of p16^INK4a/CDKN2A in human glioma. Oncogene 14:603–609, 1997Arap W, Knudsen ES, Wang JYJ, et al: Point mutations can inactivate in vitro and in vivo activities of p16^INK4a/CDKN2A in human glioma. Oncogene 14:603–609, 1997)| false
• Search Google Scholar
• Export Citation

Blanar MA, & Rutter WJ: Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-Fos. Science 256:1014–1018, 1992 Blanar MA, Rutter WJ: Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-Fos. Science 256:1014–1018, 1992

Blanar MA, Rutter WJ: Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-Fos. Science 256:1014–1018, 1992Blanar MA, Rutter WJ: Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-Fos. Science 256:1014–1018, 1992)| false
• Search Google Scholar
• Export Citation

Cairns P, , Okami K, & Halachmi S, et al: Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997–5000, 1997 Cairns P, Okami K, Halachmi S, et al: Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997–5000, 1997

Cairns P, Okami K, Halachmi S, et al: Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997–5000, 1997Cairns P, Okami K, Halachmi S, et al: Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997–5000, 1997)| false
• Search Google Scholar
• Export Citation

Chellappan SP, , Hiebert S, & Mudryj M, et al: The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061, 1991 Chellappan SP, Hiebert S, Mudryj M, et al: The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061, 1991

Chellappan SP, Hiebert S, Mudryj M, et al: The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061, 1991Chellappan SP, Hiebert S, Mudryj M, et al: The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061, 1991)| false
• Search Google Scholar
• Export Citation

Chen X, , Ko LJ, & Jayaraman L, et al: p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438–2451, 1996 Chen X, Ko LJ, Jayaraman L, et al: p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438–2451, 1996

Chen X, Ko LJ, Jayaraman L, et al: p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438–2451, 1996Chen X, Ko LJ, Jayaraman L, et al: p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438–2451, 1996)| false
• Search Google Scholar
• Export Citation

Cheney IW, , Johnson DE, & Vaillancourt MT, et al: Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 58:2331–2334, 1998 Cheney IW, Johnson DE, Vaillancourt MT, et al: Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 58:2331–2334, 1998

Cheney IW, Johnson DE, Vaillancourt MT, et al: Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 58:2331–2334, 1998Cheney IW, Johnson DE, Vaillancourt MT, et al: Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 58:2331–2334, 1998)| false
• Search Google Scholar
• Export Citation

Chuang JZ, , Lin DC, & Lin S: Molecular cloning, expression, and mapping of the high affinity actin-capping domain of chicken cardiac tensin. J Cell Biol 128:1095–1109, 1995 Chuang JZ, Lin DC, Lin S: Molecular cloning, expression, and mapping of the high affinity actin-capping domain of chicken cardiac tensin. J Cell Biol 128:1095–1109, 1995

Chuang JZ, Lin DC, Lin S: Molecular cloning, expression, and mapping of the high affinity actin-capping domain of chicken cardiac tensin. J Cell Biol 128:1095–1109, 1995Chuang JZ, Lin DC, Lin S: Molecular cloning, expression, and mapping of the high affinity actin-capping domain of chicken cardiac tensin. J Cell Biol 128:1095–1109, 1995)| false
• Search Google Scholar
• Export Citation

Collins VP, & James CD: Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 7:926–930, 1993 Collins VP, James CD: Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 7:926–930, 1993

Collins VP, James CD: Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 7:926–930, 1993Collins VP, James CD: Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 7:926–930, 1993)| false
• Search Google Scholar
• Export Citation

Cross SM, , Sanchez CA, & Morgan CA, et al: A p53-dependent mouse spindle checkpoint. Science 267:1353–1356, 1995 Cross SM, Sanchez CA, Morgan CA, et al: A p53-dependent mouse spindle checkpoint. Science 267:1353–1356, 1995

Cross SM, Sanchez CA, Morgan CA, et al: A p53-dependent mouse spindle checkpoint. Science 267:1353–1356, 1995Cross SM, Sanchez CA, Morgan CA, et al: A p53-dependent mouse spindle checkpoint. Science 267:1353–1356, 1995)| false
• Search Google Scholar
• Export Citation

Di Cristofano A, , Pesce B, & Cordon-Cardo C, et al: pten is essential for embryonic development and tumour suppression. Nat Genet 19:348–355, 1998 Di Cristofano A, Pesce B, Cordon-Cardo C, et al: pten is essential for embryonic development and tumour suppression. Nat Genet 19:348–355, 1998

Di Cristofano A, Pesce B, Cordon-Cardo C, et al: pten is essential for embryonic development and tumour suppression. Nat Genet 19:348–355, 1998Di Cristofano A, Pesce B, Cordon-Cardo C, et al: pten is essential for embryonic development and tumour suppression. Nat Genet 19:348–355, 1998)| false
• Search Google Scholar
• Export Citation

Diller L, , Kassel J, & Nelson CE, et al: p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10:5772–5781, 1990 Diller L, Kassel J, Nelson CE, et al: p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10:5772–5781, 1990

Diller L, Kassel J, Nelson CE, et al: p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10:5772–5781, 1990Diller L, Kassel J, Nelson CE, et al: p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10:5772–5781, 1990)| false
• Search Google Scholar
• Export Citation

Downward J: Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262–267, 1998 Downward J: Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262–267, 1998

Downward J: Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262–267, 1998Downward J: Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262–267, 1998)| false
• Search Google Scholar
• Export Citation

Duerr EM, , Rollbrocker B, & Hayashi Y, et al: PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259–2264, 1998 Duerr EM, Rollbrocker B, Hayashi Y, et al: PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259–2264, 1998

Duerr EM, Rollbrocker B, Hayashi Y, et al: PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259–2264, 1998Duerr EM, Rollbrocker B, Hayashi Y, et al: PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259–2264, 1998)| false
• Search Google Scholar
• Export Citation

Eng C, , Murday V, & Seal S, et al: Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J Med Genet 31:458–461, 1994 Eng C, Murday V, Seal S, et al: Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J Med Genet 31:458–461, 1994

Eng C, Murday V, Seal S, et al: Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J Med Genet 31:458–461, 1994Eng C, Murday V, Seal S, et al: Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J Med Genet 31:458–461, 1994)| false
• Search Google Scholar
• Export Citation

Eng LF: Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 8:203–214, 1985 Eng LF: Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 8:203–214, 1985

Eng LF: Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 8:203–214, 1985Eng LF: Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 8:203–214, 1985)| false
• Search Google Scholar
• Export Citation

Fults D, , Brockmeyer D, & Tullous MW, et al: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52:674–679, 1992 Fults D, Brockmeyer D, Tullous MW, et al: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52:674–679, 1992

Fults D, Brockmeyer D, Tullous MW, et al: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52:674–679, 1992Fults D, Brockmeyer D, Tullous MW, et al: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52:674–679, 1992)| false
• Search Google Scholar
• Export Citation

Furnari FB, , Huang HJS, & Cavenee WK: The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 58:5002–5008, 1998 Furnari FB, Huang HJS, Cavenee WK: The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 58:5002–5008, 1998

Furnari FB, Huang HJS, Cavenee WK: The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G₁ growth arrest in glioma cells. Cancer Res 58:5002–5008, 1998Furnari FB, Huang HJS, Cavenee WK: The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G₁ growth arrest in glioma cells. Cancer Res 58:5002–5008, 1998)| false
• Search Google Scholar
• Export Citation

Furnari FB, , Lin H, & Huang HJS, et al: Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 94:12479–12484, 1997 Furnari FB, Lin H, Huang HJS, et al: Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 94:12479–12484, 1997

Furnari FB, Lin H, Huang HJS, et al: Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 94:12479–12484, 1997Furnari FB, Lin H, Huang HJS, et al: Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 94:12479–12484, 1997)| false
• Search Google Scholar
• Export Citation

Godbout R, , Bisgrove DA, & Shkolny D, et al: Correlation of BFABP and GFAP expression in malignant glioma. Oncogene 16:1955–1962, 1998 Godbout R, Bisgrove DA, Shkolny D, et al: Correlation of BFABP and GFAP expression in malignant glioma. Oncogene 16:1955–1962, 1998

Godbout R, Bisgrove DA, Shkolny D, et al: Correlation of BFABP and GFAP expression in malignant glioma. Oncogene 16:1955–1962, 1998Godbout R, Bisgrove DA, Shkolny D, et al: Correlation of BFABP and GFAP expression in malignant glioma. Oncogene 16:1955–1962, 1998)| false
• Search Google Scholar
• Export Citation

Gomez-Manzano C, , Fueyo J, & Kyritsis AP, et al: Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56:694–699, 1996 Gomez-Manzano C, Fueyo J, Kyritsis AP, et al: Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56:694–699, 1996

Gomez-Manzano C, Fueyo J, Kyritsis AP, et al: Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56:694–699, 1996Gomez-Manzano C, Fueyo J, Kyritsis AP, et al: Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56:694–699, 1996)| false
• Search Google Scholar
• Export Citation

Gossen M, & Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547–5551, 1992 Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547–5551, 1992

Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547–5551, 1992Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547–5551, 1992)| false
• Search Google Scholar
• Export Citation

Guldberg P, , thor Straten P, & Birck A, et al: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57:3660–3663, 1997 Guldberg P, thor Straten P, Birck A, et al: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57:3660–3663, 1997

Guldberg P, thor Straten P, Birck A, et al: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57:3660–3663, 1997Guldberg P, thor Straten P, Birck A, et al: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57:3660–3663, 1997)| false
• Search Google Scholar
• Export Citation

Hartwell LH, & Kastan MB: Cell cycle control and cancer. Science 266:1821–1828, 1994 Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266:1821–1828, 1994

Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266:1821–1828, 1994Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266:1821–1828, 1994)| false
• Search Google Scholar
• Export Citation

Hunter T: A thousand and one protein kinases. Cell 50:823–829, 1987 Hunter T: A thousand and one protein kinases. Cell 50:823–829, 1987

Hunter T: A thousand and one protein kinases. Cell 50:823–829, 1987Hunter T: A thousand and one protein kinases. Cell 50:823–829, 1987)| false
• Search Google Scholar
• Export Citation

James CD, , Carlbom E, & Dumanski JP, et al: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546–5551, 1988 James CD, Carlbom E, Dumanski JP, et al: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546–5551, 1988

James CD, Carlbom E, Dumanski JP, et al: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546–5551, 1988James CD, Carlbom E, Dumanski JP, et al: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546–5551, 1988)| false
• Search Google Scholar
• Export Citation

Kleinman HK, , McGarvey ML, & Liotta LA, et al: Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21:6188–6193, 1982 Kleinman HK, McGarvey ML, Liotta LA, et al: Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21:6188–6193, 1982

Kleinman HK, McGarvey ML, Liotta LA, et al: Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21:6188–6193, 1982Kleinman HK, McGarvey ML, Liotta LA, et al: Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21:6188–6193, 1982)| false
• Search Google Scholar
• Export Citation

Kong D, , Suzuki A, & Zou TT, et al: PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 17:143–144, 1997 (Letter) Kong D, Suzuki A, Zou TT, et al: PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 17:143–144, 1997 (Letter)

Kong D, Suzuki A, Zou TT, et al: PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 17:143–144, 1997 (Letter)Kong D, Suzuki A, Zou TT, et al: PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 17:143–144, 1997 (Letter))| false
• Search Google Scholar
• Export Citation

Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88:323–331, 1997 Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88:323–331, 1997

Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88:323–331, 1997Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88:323–331, 1997)| false
• Search Google Scholar
• Export Citation

Li DM, & Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β1. Cancer Res 57:2124–2129, 1997 Li DM, Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β1. Cancer Res 57:2124–2129, 1997

Li DM, Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β₁. Cancer Res 57:2124–2129, 1997Li DM, Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β₁. Cancer Res 57:2124–2129, 1997)| false
• Search Google Scholar
• Export Citation

Li J, , Yen C, & Liaw D, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947, 1997 Li J, Yen C, Liaw D, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947, 1997

Li J, Yen C, Liaw D, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947, 1997Li J, Yen C, Liaw D, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947, 1997)| false
• Search Google Scholar
• Export Citation

Liaw D, , Marsh DJ, & Li J, et al: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67, 1997 Liaw D, Marsh DJ, Li J, et al: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67, 1997

Liaw D, Marsh DJ, Li J, et al: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67, 1997Liaw D, Marsh DJ, Li J, et al: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67, 1997)| false
• Search Google Scholar
• Export Citation

Linskey ME, & Gilbert MR: Glial differentiation: a review with implications for new directions in neuro-oncology. Neurosurgery 36:1–22, 1995 Linskey ME, Gilbert MR: Glial differentiation: a review with implications for new directions in neuro-oncology. Neurosurgery 36:1–22, 1995

Linskey ME, Gilbert MR: Glial differentiation: a review with implications for new directions in neuro-oncology. Neurosurgery 36:1–22, 1995Linskey ME, Gilbert MR: Glial differentiation: a review with implications for new directions in neuro-oncology. Neurosurgery 36:1–22, 1995)| false
• Search Google Scholar
• Export Citation

Liu W, , James CD, & Frederick L, et al: PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57:5254–5257, 1997 Liu W, James CD, Frederick L, et al: PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57:5254–5257, 1997

Liu W, James CD, Frederick L, et al: PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57:5254–5257, 1997Liu W, James CD, Frederick L, et al: PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57:5254–5257, 1997)| false
• Search Google Scholar
• Export Citation

Maehama T, & Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375–13378, 1998 Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375–13378, 1998

Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375–13378, 1998Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375–13378, 1998)| false
• Search Google Scholar
• Export Citation

Marsh DJ, , Dahia PLM, & Zheng Z, et al: Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16:333–334, 1997 Marsh DJ, Dahia PLM, Zheng Z, et al: Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16:333–334, 1997

Marsh DJ, Dahia PLM, Zheng Z, et al: Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16:333–334, 1997Marsh DJ, Dahia PLM, Zheng Z, et al: Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16:333–334, 1997)| false
• Search Google Scholar
• Export Citation

Mercer WE, , Shields MT, & Amin M, et al: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87:6166–6170, 1990 Mercer WE, Shields MT, Amin M, et al: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87:6166–6170, 1990

Mercer WE, Shields MT, Amin M, et al: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87:6166–6170, 1990Mercer WE, Shields MT, Amin M, et al: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87:6166–6170, 1990)| false
• Search Google Scholar
• Export Citation

Miyamoto S, , Akiyama SK, & Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267:883–885, 1995 Miyamoto S, Akiyama SK, Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267:883–885, 1995

Miyamoto S, Akiyama SK, Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267:883–885, 1995Miyamoto S, Akiyama SK, Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267:883–885, 1995)| false
• Search Google Scholar
• Export Citation

Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55–63, 1983 Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55–63, 1983

Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55–63, 1983Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55–63, 1983)| false
• Search Google Scholar
• Export Citation

Myers MP, , Stolarov JP, & Eng C, et al: P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94:9052–9057, 1997 Myers MP, Stolarov JP, Eng C, et al: P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94:9052–9057, 1997

Myers MP, Stolarov JP, Eng C, et al: P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94:9052–9057, 1997Myers MP, Stolarov JP, Eng C, et al: P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94:9052–9057, 1997)| false
• Search Google Scholar
• Export Citation

Nelen MR, , van Staveren WCG, & Peeters EAJ, et al: Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6:1383–1387, 1997 Nelen MR, van Staveren WCG, Peeters EAJ, et al: Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6:1383–1387, 1997

Nelen MR, van Staveren WCG, Peeters EAJ, et al: Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6:1383–1387, 1997Nelen MR, van Staveren WCG, Peeters EAJ, et al: Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6:1383–1387, 1997)| false
• Search Google Scholar
• Export Citation

Nishikawa R, , Furnari FB, & Lin H, et al: Loss of p16INK4 expression is frequent in high grade gliomas. Cancer Res 55:1941–1945, 1995 Nishikawa R, Furnari FB, Lin H, et al: Loss of p16INK4 expression is frequent in high grade gliomas. Cancer Res 55:1941–1945, 1995

Nishikawa R, Furnari FB, Lin H, et al: Loss of p16^INK4 expression is frequent in high grade gliomas. Cancer Res 55:1941–1945, 1995Nishikawa R, Furnari FB, Lin H, et al: Loss of p16^INK4 expression is frequent in high grade gliomas. Cancer Res 55:1941–1945, 1995)| false
• Search Google Scholar
• Export Citation

Ohgaki H, , Schäuble B, & zur Hausen A, et al: Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch 427:113–118, 1995 Ohgaki H, Schäuble B, zur Hausen A, et al: Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch 427:113–118, 1995

Ohgaki H, Schäuble B, zur Hausen A, et al: Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch 427:113–118, 1995Ohgaki H, Schäuble B, zur Hausen A, et al: Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch 427:113–118, 1995)| false
• Search Google Scholar
• Export Citation

Rasheed BKA, , Stenzel TT, & McLendon RE, et al: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57:4187–4190, 1997 Rasheed BKA, Stenzel TT, McLendon RE, et al: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57:4187–4190, 1997

Rasheed BKA, Stenzel TT, McLendon RE, et al: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57:4187–4190, 1997Rasheed BKA, Stenzel TT, McLendon RE, et al: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57:4187–4190, 1997)| false
• Search Google Scholar
• Export Citation

Risinger JI, , Hayes AK, & Berchuck A, et al: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57:4736–4738, 1997 Risinger JI, Hayes AK, Berchuck A, et al: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57:4736–4738, 1997

Risinger JI, Hayes AK, Berchuck A, et al: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57:4736–4738, 1997Risinger JI, Hayes AK, Berchuck A, et al: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57:4736–4738, 1997)| false
• Search Google Scholar
• Export Citation

Roche S, , Koegl M, & Courtneidge SA: The phosphatidylinositol 3-kinase is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci USA 91:9185–9189, 1994 Roche S, Koegl M, Courtneidge SA: The phosphatidylinositol 3-kinase is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci USA 91:9185–9189, 1994

Roche S, Koegl M, Courtneidge SA: The phosphatidylinositol 3-kinase is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci USA 91:9185–9189, 1994Roche S, Koegl M, Courtneidge SA: The phosphatidylinositol 3-kinase is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci USA 91:9185–9189, 1994)| false
• Search Google Scholar
• Export Citation

Russell DS, & Rubinstein LJ: Pathology of Tumours of the Nervous System, ed 5. London: Williams & Wilkins, 1989, p 6 Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System, ed 5. London: Williams & Wilkins, 1989, p 6

Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System, ed 5. London: Williams & Wilkins, 1989, p 6Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System, ed 5. London: Williams & Wilkins, 1989, p 6)| false
• Search Google Scholar
• Export Citation

Sidransky D, , Mikkelsen T, & Schwechheimer K, et al: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846–847, 1992 (Letter) Sidransky D, Mikkelsen T, Schwechheimer K, et al: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846–847, 1992 (Letter)

Sidransky D, Mikkelsen T, Schwechheimer K, et al: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846–847, 1992 (Letter)Sidransky D, Mikkelsen T, Schwechheimer K, et al: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846–847, 1992 (Letter))| false
• Search Google Scholar
• Export Citation

Steck PA, , Pershouse MA, & Jasser SA, et al: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362, 1997 Steck PA, Pershouse MA, Jasser SA, et al: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362, 1997

Steck PA, Pershouse MA, Jasser SA, et al: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362, 1997Steck PA, Pershouse MA, Jasser SA, et al: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362, 1997)| false
• Search Google Scholar
• Export Citation

Tamura M, , Gu J, & Matsumoto K, et al: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614–1617, 1998 Tamura M, Gu J, Matsumoto K, et al: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614–1617, 1998

Tamura M, Gu J, Matsumoto K, et al: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614–1617, 1998Tamura M, Gu J, Matsumoto K, et al: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614–1617, 1998)| false
• Search Google Scholar
• Export Citation

Teng DHF, , Hu R, & Lin H, et al: MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221–5225, 1997 Teng DHF, Hu R, Lin H, et al: MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221–5225, 1997

Teng DHF, Hu R, Lin H, et al: MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221–5225, 1997Teng DHF, Hu R, Lin H, et al: MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221–5225, 1997)| false
• Search Google Scholar
• Export Citation

Tohyama T, , Lee VMY, & Trojanowski JQ: Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines. Am J Pathol 142:883–892, 1993 Tohyama T, Lee VMY, Trojanowski JQ: Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines. Am J Pathol 142:883–892, 1993

Tohyama T, Lee VMY, Trojanowski JQ: Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines. Am J Pathol 142:883–892, 1993Tohyama T, Lee VMY, Trojanowski JQ: Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines. Am J Pathol 142:883–892, 1993)| false
• Search Google Scholar
• Export Citation

Van Meir E, , Ceska M, & Effenberger F, et al: Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 52:4297–4305, 1992 Van Meir E, Ceska M, Effenberger F, et al: Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 52:4297–4305, 1992

Van Meir E, Ceska M, Effenberger F, et al: Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 52:4297–4305, 1992Van Meir E, Ceska M, Effenberger F, et al: Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 52:4297–4305, 1992)| false
• Search Google Scholar
• Export Citation

Van Meir EG, , Kikuchi T, & Tada M, et al: Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54:649–652, 1994 Van Meir EG, Kikuchi T, Tada M, et al: Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54:649–652, 1994

Van Meir EG, Kikuchi T, Tada M, et al: Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54:649–652, 1994Van Meir EG, Kikuchi T, Tada M, et al: Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54:649–652, 1994)| false
• Search Google Scholar
• Export Citation

Wang SI, , Puc J, & Li J, et al: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57:4183–4186, 1997 Wang SI, Puc J, Li J, et al: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57:4183–4186, 1997

Wang SI, Puc J, Li J, et al: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57:4183–4186, 1997Wang SI, Puc J, Li J, et al: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57:4183–4186, 1997)| false
• Search Google Scholar
• Export Citation

Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81:323–330, 1995 Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81:323–330, 1995

Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81:323–330, 1995Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81:323–330, 1995)| false
• Search Google Scholar
• Export Citation

Wilkins JA, , Risinger MA, & Lin S: Studies on proteins that copurify with smooth muscle vinculin: identification of immunologically related species in focal adhesions of nonmuscle and Z-lines of muscle cells. J Cell Biol 103:1483–1494, 1986 Wilkins JA, Risinger MA, Lin S: Studies on proteins that copurify with smooth muscle vinculin: identification of immunologically related species in focal adhesions of nonmuscle and Z-lines of muscle cells. J Cell Biol 103:1483–1494, 1986

Wilkins JA, Risinger MA, Lin S: Studies on proteins that copurify with smooth muscle vinculin: identification of immunologically related species in focal adhesions of nonmuscle and Z-lines of muscle cells. J Cell Biol 103:1483–1494, 1986Wilkins JA, Risinger MA, Lin S: Studies on proteins that copurify with smooth muscle vinculin: identification of immunologically related species in focal adhesions of nonmuscle and Z-lines of muscle cells. J Cell Biol 103:1483–1494, 1986)| false
• Search Google Scholar
• Export Citation

Zieve GW, , Turnbull D, & Mullins JM, et al: Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazol. Nocodazole accumulated mitotic cells. Exp Cell Res 126:397–405, 1980 Zieve GW, Turnbull D, Mullins JM, et al: Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazol. Nocodazole accumulated mitotic cells. Exp Cell Res 126:397–405, 1980

Zieve GW, Turnbull D, Mullins JM, et al: Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazol. Nocodazole accumulated mitotic cells. Exp Cell Res 126:397–405, 1980Zieve GW, Turnbull D, Mullins JM, et al: Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazol. Nocodazole accumulated mitotic cells. Exp Cell Res 126:397–405, 1980)| false
• Search Google Scholar
• Export Citation